Becky Butler Cap

Chief Operating Officer, GenCure,
Senior Vice President, BioBridge Global

Becky Cap, a 20-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February, 2016. In her position, Cap has advanced the development of GenCure’s biomanufacturing facilities and capabilities to help fulfill the mission of realizing the potential of donated human cells and tissue to save and enhance lives.

Cap, a native of Texas, earned a bachelor’s degree from Harvard University. She began her career at Dana-Farber Cancer Institute in Boston, where she gained clinical, laboratory and regulatory experience.

While pursuing her MBA at Boston University’s Health Care Management Program, she began her career in consulting with Eidetics, a firm focused on informing biomedical product development, where her focus was largely on oncology product development. She also has run her own consulting firm and worked with a number of local startups.

Cap has provided strategic guidance for the development of pharmaceuticals and extensive entrepreneurial coaching. She is an active member of local and national committees on Regenerative Medicine and Cell Therapy. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.

Read more

Mike Fiske

Vice President of Cell Manufacturing

Mike Fiske has more than 25 years in the biotechnology industry as a protein chemist, process biochemist and operations manager. He serves as Vice President of Cell Manufacturing at GenCure, which operates a multiuse, cGMP-compliant, contract manufacturing facility designed for the development and manufacture of cell therapy products.

He has extensive background in cGMP, including facility design, construction and startup, validation and qualification, process development, analytical methods development, and production. He also has experience in the QC testing of clinical-grade materials including vaccines, protein-based cancer therapeutics and cell therapy products.

As Vice President, Fiske oversees the ongoing facility operations including new facility construction, validation, technology transfer, clinical-scale process and analytical methods development, cGMP manufacturing and QC testing of preclinical and clinical-grade cell therapy products. He is also responsible for providing assistance to clients with preparation of regulatory documents and interactions with regulatory agencies.

Read more

Christie Malone

Corporate Account Executive, GenCure

A 25-year industry veteran, Christie Malone is the Corporate Account Executive at GenCure. Malone focuses on advancing the organization’s strategic collaborations with not only therapeutic cell and cell & gene therapy companies in every stage of the product development pipeline, but also the companies that provide tools to facilitate clinical product manufacturing.

Since joining GenCure in 2017, Malone has established GenCure as a preferred contract development and manufacturing organization for the cell and gene therapy marketplace, ensuring client satisfaction and enduring trust as a long-term partner.

Her current role relies on more than 2 decades experience in transfusion medicine, which includes pediatric transfusion practice, blood center immunohematology and infectious disease testing. She also has experience in sales and marketing of 510k-regulated, closed-system medical devices.

Read more